Correction: Incorrect MAR Classification in previous press release
Lund, Sweden – 12 April 2019 – Dignitana AB issues a correction in press release "Dignitana AB publishes the annual report for 2018." The correction means that the press release was incorrectly classified as MAR and therefore contained the paragraph as follows:
"This information is such information that Dignitana AB (publ) is obliged to disclose in accordance with the EU Market Abuse Regulation. The information was provided through the above persons for publication at 08:00 (CET), on April 12, 2019."
The press release should not have included this paragraph because it is not classified as MAR.
William Cronin, Chief Executive Officer, Dignitana AB email@example.com +1 469 917 5555
Mikael Wahlgren, Deputy Managing Director, Dignitana AB firstname.lastname@example.org +46 709 33 72 20
About Dignitana AB (publ)
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and acceptable patient comfort. Dignitana AB is listed on Nasdaq First North Stockholm in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Erik Penser Bank is Certified Adviser. Learn more at www.dignitana.se and www.dignicap.com.